Skip Navigation
Return to All Schools

The David Goldfarb, M.D. Endowed Research Professorship in Vascular Surgery

School of Medicine

Established in 2014

Ring.TimothyMr. TIMOTHY M. RING was named Chairman and Chief Executive Officer for C. R. Bard, Inc. as of August 8, 2003. He joined Bard in June 1992 as Corporate Vice President – Human Resources and was promoted to Group Vice President – International in December 1993. In November 1995, he was given additional responsibility for Interventional Cardiology and Electrophysiology. In January 1997, he also assumed additional responsibility for the Cardiac Assist and Cardiopulmonary Divisions and in April 1997, he was promoted to Group President for Coronary Vascular Products. In 1999, he was named Group President for Bard Electrophysiology and Peripheral Vascular Products and in 2002 was given additional responsibility for Bard Access Systems, Bard Europe and Corporate Healthcare Services.

Prior to Bard, he worked for Abbott Laboratories for nearly 10 years, most recently as Director of Personnel for the Hospital Products Division. Before that, he was General Manager for Abbott’s Australian, New Zealand and Indonesian operations, residing in Sydney. Prior to that, he was Director of Personnel for Pacific/Asia/Africa and Europe. From 1984 to 1986, he was also Director of Personnel for Latin America & South East Asia. He started at Abbott in 1983 as Assistant Personnel Manager for the Pharmaceutical Division. Before joining Abbott, Mr. Ring was employed by The General Motors Corporation. Mr. Ring has a B.S. in Industrial and Labor Relations from Cornell University.

He is a trustee for the New Jersey Health Foundation (NJHF) and former Chairman of the Board of Trustees of the HealthCare Institute of New Jersey (HINJ). Mr. Ring is also a member of the Board of Directors for C. R. Bard, Inc., Quest Diagnostics, AdvaMed, the medical device industry association, NAM (National Association of Manufacturers), and InHealth. He is also a member of the Cornell University Trustee Council and a vice chairman on the Kennedy Center Corporate Fund Board in Washington, DC.

Weiland.JohnJOHN H. WEILAND joined C.R. Bard, Inc. on March 1, 1996. His experience spans over 35 years in the healthcare industry with firms such as Dentsply International, Pharmacia and Baxter Healthcare Corporation.

John was named President and Chief Operating Officer of C.R. Bard on August 8, 2003, having worldwide responsibility for all of Bard’s business operations. He was elected to Bard’s board of directors on April 20, 2005. Prior to becoming President and COO, John held the position of Group President of Bard. C. R. Bard, Inc. is a multinational medical device firm headquartered in Murray Hill, New Jersey. The company is publicly traded on the New York Stock Exchange and has over 12,000 employees worldwide.

Prior to Bard, John held the position of Senior Vice President North America Group for Dentsply International in York, Pennsylvania. This position included general management responsibility for the eleven operating divisions of Dentsply International, the world’s leading dental products manufacturer.

John graduated from DeSales University with a BS degree and earned an MBA degree from New York University. John started his career at Baxter/American Hospital Supply Corporation in 1977 as a sales representative. He rose through numerous managerial positions to become Vice President and General Manager of the Scientific Products Biomedical Division. In 1989, he became President and Chief Executive Officer of Pharmacia Diagnostics, a division of Pharmacia AB Uppsala Sweden.

In addition to his professional activities, John is actively involved in civic affairs. In 1987, John was named a White House Fellow and served as a Special Assistant to two members of President Reagan’s Cabinet. In 2012, John was the recipient of the distinguished Horatio Alger Award. He is a member of the Board of Directors of West Pharmaceutical Services, Inc. and the Horatio Alger Association.

John, his wife Kathy, and their three children reside in Brick, New Jersey.

Goldfarb.DavidDAVID GOLDFARB was born on February 26, 1938 in New York City and was raised in Rutherford, New Jersey. After graduating from Rutherford High School in 1955, he attended The Johns Hopkins University where he earned his undergraduate degree in Arts and Sciences in 1959 and his medical degree in 1963. During his time in medical school, Dr. Goldfarb was awarded the Henry Strong Denison Scholarship for Meritorious Research in recognition of the superiority, originality, and quality of his independent work. He completed his surgical residency at Johns Hopkins under Dr. Alfred Blalock, Dr. Helen Taussig, and Dr. Henry Bahnson and finished his training at the University of Pittsburgh. In 1973, Dr. Goldfarb moved to Phoenix, Arizona to establish a pediatric heart surgery practice at the Arizona Heart Center. He also continued his medical research on artificial hearts and blood vessels at Arizona State University. Dr. Goldfarb was named one of the best doctors in Arizona several times, and, in 1999, he was awarded the Dr. Joseph Ehrlich Medal for Medical Excellence by the Maricopa County Medical Society for his commitment to caring service to countless patients in need regardless of status. As a young surgical resident, Dr. Goldfarb was fascinated by cardiovascular surgery, a field in its early stages. While training under his mentor, Dr. Henry Bahnson, he developed an interest in developing artificial vascular grafts that could be used to repair the body’s veins, arteries, and other cardiac structures. It was this interest that led him to invent a breakthrough vascular graft in the early 1970s that is still widely used in cardiac surgery today. Dr. Goldfarb is a great lover of the outdoors, and he and his wife, Joan, are active members of their communities in Arizona and Jackson Hole, Wyoming. They remain dedicated members of the Johns Hopkins family, established an endowed scholarship at the School of Medicine, participated in alumni activities in Arizona, and returned to Baltimore for many School of Medicine Biennial celebrations. They have five children, Melissa, Michael, Josh, Jill, and Abbie. Dr. Goldfarb’s quiet and generous donations to medical education, the elderly, and the poor represent the true spirit of medicine.

Held by James H. Black

Black.JamesJAMES H. BLACK, the David Goldfarb Research Professor of Surgery, is an associate professor of surgery in the Division of Vascular Surgery. He is also an assistant program director for the Halsted Training Program in General Surgery and serves as the program director for the Vascular Surgery Fellowship. Dr. Black directly mentors ten residents, varying from interns to chief residents, to assist and promote their didactic education and sits on the residency promotion committee for the General Surgery Program.

Dr. Black’s clinical expertise includes performance of complex aortic surgery, including thoracoabdominal aortic repairs, the most challenging operation in vascular surgery. He has gained national recognition for his care of patients with connective tissue disorders, particularly those afflicted by Ehlers-Danlos Syndrome, in whom presentations often have very technically demanding repair.

He serves as a peer reviewer for several surgical journals, including the leading international vascular surgical journal, the Journal of Vascular Surgery. Dr. Black was recently distinguished as a “Key Reviewer” for this journal, a categorization reserved for those who submit the most outstanding article reviews. He has also been a featured speaker at the annual meeting of the Society for Vascular Surgery, discussing aortic dissections, the cost of thoracic aortic replacement, and the manifestations of Loeys-Dietz Syndrome. Dr. Black has lectured internationally regarding the complex aortic surgery techniques he has mastered and developed. Reflecting the value of his clinical scholarship, the Ehlers-Danlos National Foundation named him to the national advisory board for Vascular Ehlers-Danlos Syndrome.